Bolt Biotherapeutics

BOLT · NASDAQ

$4.31+$0.27 (+6.68%)TodayMarket closed ·
Prev close $4.04

Who owns BOLT

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 28.4% of BOLT’s shares.

  • Sofinnova Investments, Inc7.2%
  • Renaissance Technologies LLC5.1%
  • Vivo Capital, LLC3.8%
  • Citadel Advisors LLC3.0%
  • Next 6 largest institutions9.3%
  • All other shareholders71.6%
Top institutional holders of BOLT
HolderShares% of shares
Sofinnova Investments, Inc137.72K7.17%
Renaissance Technologies LLC98.63K5.14%
Vivo Capital, LLC72.41K3.77%
Citadel Advisors LLC56.90K2.96%
T3 Companies, LLC38.00K1.98%
Stanford Management Company35.98K1.87%
Pfizer Inc.31.30K1.63%
Lynx1 Capital Advisors LLC30.80K1.60%
Nemec (Sarah)23.95K1.25%
Geode Capital Management, L.L.C.19.12K1.00%

Largest mutual fund holders

Top mutual fund holders of BOLT
HolderShares% of shares
Fidelity Extended Market Index Fund7.51K0.39%
Vanguard Extended Market Index Fund7.06K0.37%
Fidelity Total Market Index Fund5.35K0.28%
Fidelity Series Total Market Index Fund1.70K0.09%
BlackRock Diversified Equity Alpha Fund890.00%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $4.44K (2 trades) and sold $128.28K (9 trades) of BOLT on the open market.

Latest BOLT insider transactions
InsiderTypeSharesValue
Nemec SarahSale4.08K$13.19K
Quinn William P.Sale9.13K$29.55K
Yonehiro GrantSale6.85K$22.17K
Nemec SarahSale2.92K$9.70K
Quinn William P.Sale6.54K$21.72K
Yonehiro GrantSale4.91K$16.29K
Nemec SarahSale843$3.18K
Quinn William P.Sale1.89K$7.13K
Yonehiro GrantSale1.42K$5.35K
Berner LauraAward5.00K—

Short interest

Settled Sep 30, 2026

Shares short
25.74K
Days to cover
1.00
% of shares outstanding
1.34%
Average daily volume
42.28K
Change since last report
+39.2%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.